CIM
ABEO icon

CIM Investment Management’s Abeona Therapeutics ABEO Stock Holding History

CIM Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,281
Closed -$236K – 316
2019
Q1 		$236K Sell
1,281
-11
-0.9% -$1.97K 0.09% 284
2018
Q4 		$231K Hold
1,292
– – 0.1% 257
2018
Q3 		$413K Hold
1,292
– – 0.15% 191
2018
Q2 		$517K Hold
1,292
– – 0.18% 153
2018
Q1 		$464K Buy
+1,292
New +$480K 0.16% 184

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIM Investment Management's ABEO Position: Q2 2019 in Review

CIM Investment Management sold out of Abeona Therapeutics (ABEO) in Q2 2019, closing a stake of 1,281 shares — an estimated $236K sold.

CIM Investment Management first reported a position in ABEO in Q1 2018 and held it in 5 quarters. The position peaked at $517K in Q2 2018. 98 funds tracked by Wall St. Rank hold ABEO as of Q2 2019.

  • CIM Investment Management reported no remaining Abeona Therapeutics position as of Q2 2019 after selling out during the quarter.
  • CIM Investment Management sold 1,281 Abeona Therapeutics shares in Q2 2019, an estimated $236K.
  • CIM Investment Management first reported a position in Abeona Therapeutics in Q1 2018 and held it in 5 quarters.
  • CIM Investment Management's Abeona Therapeutics position peaked at $517K in Q2 2018.
  • 98 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2019.

Based on CIM Investment Management's 13F filing for Q2 2019, filed 8 Aug 2019.